ARC

May 14 2026ENVIRONMENT

Understanding PFAS in Compost: What Happens When Organic Waste Breaks Down

When organic waste like food scraps and yard trimmings gets turned into compost, it doesn’t just turn into soil. It also mixes with biosolids—treated sewage sludge—creating a nutrient-rich product used in gardens and farms. But there’s a catch: compost can contain PFAS, a group of man-made chemicals

reading time less than a minute
May 14 2026POLITICS

Big Day for the PM, Bigger Problems at Home

The annual State Opening of Parliament is usually a show of tradition and stability in British politics. This year, it became another pressure point for Prime Minister Keir Starmer. Just hours before King Charles delivered a speech outlining the government's plans, whispers turned into real talk—Hea

reading time less than a minute
May 14 2026HEALTH

When Memory Fades, Moments of Clarity Appear

Around four in every ten people caring for those with memory loss have seen surprising moments of sharpness. That's what a large nationwide study discovered after surveying nearly 6, 000 caregivers and family members. These brief returns to clarity happen to patients with Alzheimer's or other memor

reading time less than a minute
May 13 2026HEALTH

Ewing and Other Small‑Round Tumors: What the DNA Tells Us

Ewing sarcoma is a fast‑growing bone tumor that shows up mostly in teenagers and young adults. It carries a special genetic swap, called a FET::ETS rearrangement, that scientists can spot with a test. \ Other tumors that look the same under the microscope – the non‑Ewing small‑round cell sarco

reading time less than a minute
May 13 2026TECHNOLOGY

How Tech Foundations Use Money to Push Research Forward

A little-known financial trick gives some tech organizations an edge in research. By selling a slice of their company, they unlock funds for big projects without borrowing money. One group used this method to fuel studies on brain diseases like Alzheimer’s. Instead of waiting for grants or donations

reading time less than a minute
May 12 2026HEALTH

How Migraine Patients Use Healthcare When Standard Treatments Fail

For many people with stubborn migraines that don’t respond to usual treatments, life becomes a cycle of doctor visits, tests, and trial-and-error medications. Research shows these patients often need more than the standard three attempts at preventive drugs before finding something that works. But w

reading time less than a minute
May 12 2026SCIENCE

Brain cells that change roles: What this new study tells us about brain health

Scientists recently corrected a key research paper about brain cells called microglia. These tiny cells act like the brain’s cleanup crew and defense team mixed together. Instead of being identical, they switch between different roles depending on what the brain needs at the time. This flexibility h

reading time less than a minute
May 12 2026POLITICS

Science Advice in Danger: Why Losing the National Science Board Matters

Over two thousand researchers signed a letter last week warning that getting rid of the National Science Board weakens America’s position against countries like China. The board, created in 1950, used to guide how taxpayer money supports science and engineering research. Its twenty-plus members, app

reading time less than a minute
May 12 2026ENVIRONMENT

How Climate Shifts Can Tip the Balance Toward Conflict

Scientists have found that not all climate changes affect violence the same way. Two well-known patterns—the Pacific warming called El Niño and the Indian Ocean temperature flip called the Indian Ocean Dipole—can quietly push societies toward fighting, even when people don’t immediately notice the d

reading time less than a minute
May 12 2026HEALTH

Why ALS Drug Research Struggles and How to Fix It

ALS is a rare but cruel disease that slowly shuts down the body while leaving the mind intact. Doctors have only approved three drugs for it since the mid-1990s, and none of them cure or stop the disease—they merely slow it down a little. Part of the problem is money. Running trials for ALS is extre

reading time less than a minute